Deal facts
- Buyer
- FONAR, LLC
- Target
- FONAR Corporation
- Deal value
- Not disclosed
- Announced
- 3 June 2026
- Status
- Completed
- Sector
- Healthcare
- Country
- United States
- Consideration
- cash
Sources
FONAR, LLC has agreed to acquire FONAR Corporation in a going private transaction completed on 3 June 2026. The deal involves the purchase of the US-based healthcare company by a US buyer using cash consideration. Although the specific headline offer value was not reported, the transaction structure indicates a complete change in ownership status for the target entity. The announcement and completion occurred on the same date, marking an immediate shift in the corporate structure of the business.
The transaction is now final following the completion of all necessary steps on the announcement date. Regulatory approvals and other standard conditions have been satisfied to allow the deal to close. This acquisition removes the company from public markets, placing it under private ownership. The parties have successfully concluded the process without further delays or outstanding conditions.
More M&A Tools
Explore the Toolkit
Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.
Access nowDeal timeline
1 update- CompletedClosed
FONAR, LLC completes acquisition of FONAR Corporation
Item 1.01 Entry into a Material Definitive Agreement. The information set forth in the Introduction to this Current Report on Form 8-K (the “ Introduction ”) is incorporated into this Item 1.01 by reference. Credit Agreement In connection with the Closing, Parent and the Company (as successor in interest to Merger Sub by way of the Merger), as borrowers, entered into a Credit Agreement with OceanF
Source
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
Trafalgar Asset Management, LLC to acquire The Greater Cannabis Company, Inc.
Trafalgar Asset Management, LLC has agreed to acquire The Greater Cannabis Company, Inc. in a going private transaction. The deal was announced on 6 July 2026, following…
- Buyer
- Trafalgar Asset Management, LLC
- Target
- The Greater Cannabis Company, Inc.
- Deal value
- Not disclosed
- Deal type
- going private
Hanmi Pharmaceuticals Co. Ltd. to acquire Aptose Biosciences Inc.
Hanmi Pharmaceuticals Co. Ltd. has agreed to acquire Aptose Biosciences Inc. in a going private transaction valued at USD 3,466,470. The consideration for this deal cons…
- Buyer
- Hanmi Pharmaceuticals Co. Ltd.
- Target
- Aptose Biosciences Inc.
- Deal value
- USD 3,466,470
- Deal type
- going private
GlaxoSmithKline LLC to acquire Nuvalent, Inc.
GlaxoSmithKline LLC has agreed to acquire Nuvalent, Inc. in a going private transaction. The deal was announced on 9 June 2026 and completed on 15 July 2026. The conside…
- Buyer
- GlaxoSmithKline LLC
- Target
- Nuvalent, Inc.
- Deal value
- Not disclosed
- Deal type
- going private
Zydus Worldwide DMCC to acquire Assertio Holdings, Inc.
Zydus Worldwide DMCC has agreed to acquire Assertio Holdings, Inc. in a going private transaction valued at an undisclosed amount. The deal, announced on 13 May 2026, wa…
- Buyer
- Zydus Worldwide DMCC
- Target
- Assertio Holdings, Inc.
- Deal value
- Not disclosed
- Deal type
- going private
Merck to acquire Terns Pharmaceuticals, Inc.
Merck and Terns Pharmaceuticals, Inc. entered the Exit Mode archive.
- Buyer
- Merck
- Target
- Terns Pharmaceuticals, Inc.
- Deal value
- Not disclosed
- Deal type
- going private
Buyer history
FONAR, LLC
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive